Skip to main content



 

Imaging in Drug Delivery (CRS/ESMI)


Imaging in drug delivery: imaging of drug delivery for monitoring disease progression, biodistribution, nanoparticle kinetics, etc; image-guided drug delivery (TACE, SIRT, HIFU, etc.); theranostics; companion diagnostics; and nanomedicine-based patient stratification.


Poster # First Name Last Name Abstract Title Abstract
286
Kai Liu Unveiling the Biological Identity of Lipid Nanoparticles View
330 Maytal Avrashami Aggregation Induced Emission Based Method to Evaluate Drug Penetration and Delivery in 3D Tumor Spheroids View
331 Adilet Beishenaliev Development of Gadolinium-conjugated ultrasmall gold nanoparticles for breast cancer imaging View
332 Amina Benaicha Fernández Zinc phthalocyanine-initiated poly-L-glutamate-based nanocarriers with theranostic properties for glioblastoma multiforme treatment View
333 Karina Benderski Development and characterization of fibrotic and non-fibrotic hepatocellular carcinoma models for assessing anticancer nanotherapies View
334 Natalie Boykoff A Multimodal Theranostic Agent with Enhanced Cerenkov Luminescence Imaging View
335 Roberta Censi Design of PFCE Encapsulated Nanoparticles for FMRI application based on PLGA and its derivatives View
336 Axelle Grandé Exploring the potential of engineered nanocarriers on host directed therapy against tuberculosis. View
337 Antoni Serrano Martí. Characterization of a bone metastatic prostate cancer model and validation as a platform for nanomedicine evaluation View
338 Qingrong Jiang Microfluidic controllable preparation of iodine-131-labeled microspheres for radioembolization therapy of liver tumors View
340 Caroline Roques Nanoformulated EPR probes for the evaluation of oxidative stress View
341 Alec Wang Development of Theranostic Polymeric Micelles for Image-Guided Cancer Nanotherapy View
423 Jason Li Effortless Adherence to Long-Term Obesity Treatment via automated sequential drug Releasing Intervals for Personalized Extended therapy (RIPE) in Large Animals View